4 Stocks Are Inspired on Friday to Investor ( CEL, RTK, SNSS, RYL )

Los Angelas, CA -- (SBWIRE) -- 09/21/2012 -- Cellcom Israel, L (NYSE:CEL) is +0.49 - +5.90% from the previous close of $8.31. It traded between $8.33 - 8.99 with total traded volume of 970722 shares. At Current Market Price, CEL is in distance of +24.33% from its 50-day Moving Average price of $7.0777 and +0.76% from its 200-day Moving Average price of $8.7337. Barclays Capital upgraded shares of Cellcom Israel (NYSE: CEL) from an underweight rating to an equal weight rating in a research report sent to investors on Thursday Morning. Separately, analysts at UBS AG upgraded shares of Cellcom Israel from a neutral rating to a buy rating in a research note to investors. Cellcom Israel Ltd. (Cellcom) is a provider of cellular communications services in Israel. The Company offers a range of cellular services through its cellular networks.

Is CEL going to move higher as many investors expect : Find Out Here

Rentech, Inc. Com (AMEX:RTK) is very active today and traded between $2.46 - 2.64 with total traded volume of 3643346 shares. At a current price of 2.64, RTK is +0.13 - +5.18% from the previous close of $2.51. Moreover, At Current Market Price, RTK is in distance of +16.12% from its 50-day Moving Average price of $2.2734 and +28.47% from its 200-day Moving Average price of $2.0549.

Is RTK going to move higher as many investors expect : Find Out Here

Sunesis Pharmaceu (NCM:SNSS) is -0.13 - -2.51% from the previous close of $5.18. It traded between $4.92 - 5.41 with total traded volume of 1456334 shares. At Current Market Price, SNSS is in distance of +44.84% from its 50-day Moving Average price of $3.4866 and +70.60% from its 200-day Moving Average price of $2.9602. Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS): Shares of the South San Francisco, California-based biopharmaceutical company hit a 52-week high of $5.41 in trading today. At last check, SNSS shares were trading 4.05% higher at $5.39 on volume of 405,459. SNSS today closed two previously announced financings. SNSS received a $25 million investment from Royalty Pharma under a royalty agreement between the two companies. In a separate transaction, a syndicate of lenders, which is led by Oxford Finance, funded the second tranche of $15 million under their $25 million loan facility with SNSS.

Is SNSS going to move higher as many investors expect : Find Out Here

Ryland Group, Inc (NYSE:RYL) is +0.81 - +2.55% from the previous close of $31.80. It traded between $31.62 - 32.90 with total traded volume of 1967077 shares. At Current Market Price, RYL is in distance of +21.26% from its 50-day Moving Average price of $26.8926 and +41.25% from its 200-day Moving Average price of $23.0869. Ryland Group (NYSE:RYL): Due to the Federal Reserves most recent stimulus attempts, banks are expected to see a “windfall,” but it could be months before a decline is seen in mortgage rates because of the central bank’s action, according to The Washington Post, who cited analysts as saying yesterday. The shares closed at $31.80, up $1.72 or 5.72% on the day. They have traded in a 52-week range of $9.15 to $31.55.

Is RYL going to move higher as many investors expect : Find Out Here

Disclaimer:
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com